Education
About Us
Working with TipRanks
Follow Us
Evommune, Inc. (EVMN)
NYSE:EVMN
| Dec 24 | Dec 23 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 7.00M | $ 5.00M |
| Gross Profit | $ 5.71M | $ 4.00M |
| Operating Income | $ -70.01M | $ -37.85M |
| EBITDA | $ -65.49M | $ -32.99M |
| Net Income | $ -66.81M | $ -34.05M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 72.04M | $ 79.08M |
| Total Assets | $ 76.06M | $ 82.25M |
| Total Debt | $ 193.31M | $ 150.63M |
| Net Debt | $ 177.06M | $ 121.61M |
| Total Liabilities | $ 220.29M | $ 159.96M |
| Stockholders' Equity | $ -144.24M | $ -77.71M |
| Cash Flow | ||
| Free Cash Flow | $ -58.28M | $ -30.09M |
| Operating Cash Flow | $ -58.20M | $ -29.97M |
| Investing Cash Flow | $ -3.99M | $ -48.43M |
| Financing Cash Flow | $ 49.42M | $ 63.75M |